译语翻译分享-专家称明年九价HPV短缺或缓解，我国有近10余家药厂做HPV疫苗

专家称明年九价HPV短缺或缓解，我国有近10余家药厂做HPV疫苗

Experts say that next year’s Nine-valent vaccine shortage or alleviation, there are nearly 10 pharmaceutical factories in my country making HPV vaccines

据央视网报道，北京协和医学院群医学及公共卫生学院教授乔友林表示，此前的进口二价、四价HPV疫苗都经过了8年的临床试验过程，但国家药监局在9天之内有条件批准了九价HPV疫苗。

According to a CCTV report, Qiao Youlin, a professor at the School of Medicine and Public Health of Peking Union Medical College, said that the previous imported bivalent and quadri-valent HPV vaccines have gone through 8 years of clinical trials, but the State Food and Drug Administration Conditions approved the nine-valent HPV vaccine.

“疫苗厂商根本就没有预料到中国的九价苗9天之内就能上市，因此它的生产计划根本就没有安排，突然一下批准了，他们为了满足中国大陆的需要，把其他国家的配额减低以保证中国的供应，但还是不够”。

"Vaccine manufacturers never expected that China's 9-valent vaccine would be available within 9 days. Therefore, its production plan was not arranged at all. It was suddenly approved. In order to meet the needs of mainland China, they reduced the quotas of other countries. To ensure China’s supply, it is still not enough."

他透露，“九价苗生产公司默沙东也在加大它的产能，明年就会大量增加对中国的供应。我们国家还有近10余家药厂都在做HPV的疫苗，所以在今后的几年之内，还会不断地有疫苗推向市场，到那个时候疫苗就真正可以全程覆盖了，这问题不大。”

He revealed, “Nine-valent vaccine production company Merck is also increasing its production capacity and will substantially increase its supply to China next year. There are still more than 10 pharmaceutical factories in our country that are making HPV vaccines, so in the next few years, Within a year, vaccines will continue to be introduced to the market. By that time, vaccines will truly cover the entire process. This is not a big problem."

1、什么是九价HPV疫苗？

1. What is a nine-valent HPV vaccine?

九价HPV疫苗，是用于预防人乳头瘤病毒（HPV）感染引起的宫颈癌，可以预防90%以上的宫颈癌。疫苗于2014年在美国获批上市。2018年4月28日，国家药品监督管理局有条件批准用于预防宫颈癌的九价HPV疫苗在中国上市。

The nine-valent HPV vaccine is used to prevent cervical cancer caused by human papillomavirus (HPV) infection and can prevent more than 90% of cervical cancers. The vaccine was approved for marketing in the United States in 2014. On April 28, 2018, the National Medical Products Administration had conditionally approved the nine-valent HPV vaccine for the prevention of cervical cancer to be marketed in China.

2、HPV的感染率高吗？

2. Is the HPV infection rate high?

HPV病毒感染率极高，80—90%有性生活的女性在一生中都有可能感染HPV，不过大部分HPV感染后可以自动清除，但特定类型的持续性感染就有可能进展为宫颈癌。

The HPV virus infection rate is extremely high. 80-90% of women who have sex may be infected with HPV in their lifetime. However, most HPV infections can be automatically cleared, but certain types of persistent infections may progress to cervical cancer.

3、HPV疫苗安全吗？

3. Is the HPV vaccine safe?

HPV疫苗已在全球使用数十年，被证实具有良好的安全性。绝大部分人接种后没有不良反应。少数人会有一些轻微反应，如接种部位红肿、疼痛、发热、头疼、疲倦、恶心、肌肉或关节酸痛的症状，但通常会很快康复。

The HPV vaccine has been used around the world for decades and has been proven to have good safety. The vast majority of people have no adverse reactions after vaccination. A small number of people will have some mild reactions, such as swelling, pain, fever, headache, fatigue, nausea, muscle or joint pain, but usually recover quickly.

From website: https://cj.sina.com.cn/